Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.

about

Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity.

P2860

Q41097996-DDF26B97-AEAF-4580-BB6D-F7CDCA173297

P2860

Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.

Item

http://www.wikidata.org/entity/Q55711702

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Single-base LOH can be used as ...... into More Homogenous Subtypes.

@en

Single-base LOH can be used as ...... into More Homogenous Subtypes.

@nl

type

Item

label

Single-base LOH can be used as ...... into More Homogenous Subtypes.

@en

Single-base LOH can be used as ...... into More Homogenous Subtypes.

@nl

prefLabel

Single-base LOH can be used as ...... into More Homogenous Subtypes.

@en

Single-base LOH can be used as ...... into More Homogenous Subtypes.

@nl

P1476

Single-base LOH can be used as ...... into More Homogenous Subtypes.

@en

P2093

Bradley Downs

http://www.w3.org/2001/XMLSchema#string

Dali Huang

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Fleissner

http://www.w3.org/2001/XMLSchema#string

Fengxia Xiao

http://www.w3.org/2001/XMLSchema#string

Kenneth Cowan

http://www.w3.org/2001/XMLSchema#string

Pei Xian Chen

http://www.w3.org/2001/XMLSchema#string

San Ming Wang

http://www.w3.org/2001/XMLSchema#string

Yeong C Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Individualized medicine from prewomb to tomb

Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.

Single nucleotide polymorphism (SNP)-based loss of heterozygosity (LOH) testing by real time PCR in patients suspect of myeloproliferative disease

MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours.

Pathology of hereditary breast cancer.

Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning?

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.

Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families.

Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

P304

479-481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TBJ.12777

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28117528

http://www.w3.org/2001/XMLSchema#string

P932

5505784

http://www.w3.org/2001/XMLSchema#string

Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.

about

P2860

P2860

Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932